Fibrotic disease and the TH1/TH2 paradigm
Open accessThe DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, interferon-γ (IFNγ), produced by many immune cells including NK, NKT and T cells, has direct anti-fibrogenic activity on HSCs (70–72).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [71]
Experimental — accuracy not yet measuredIn the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Normally, myofibroblasts carefully coordinate the breakdown of granulation tissue and replacement with long-lasting type I collagen [100].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737 · cited 1×
“However, it is now described as a general immunosuppressive cytokine that downregulates chronic inflammatory responses through many mechanism”
BackgroundAlternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,529
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890
Requirement for IL-13 Independently of IL-4 in Experimental Asthma
Grünig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998) · Science · doi:10.1126/science.282.5397.2261 · Cited by 1,849
Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719
Cited by
Items 901–1,000 of 1,000
Kato, K., Papageorgiou, I., Shin, Y.-J., Kleinhenz, J., Palumbo, S., Hahn, S., Irish, J. D., Rounseville, S. P., Knox, K. S., & Hecker, L. (2022) · Antioxidants · doi:10.3390/antiox11030492 · Cited by 26
Dhingra, S., Mahadik, J. D., Tarabishy, Y., May, S., & Vierling, J. M. (2022) · Pathology · doi:10.1016/j.pathol.2022.01.009 · Cited by 25
Genetic susceptibility in pneumoconiosis in China: a systematic review
Chair, S. Y., Chan, J. Y., Law, B. M. H., Waye, M. M. Y., & Chien, W. T. (2022) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-022-01893-1 · Cited by 23
Tolerizing allergic responses in the lung
Lloyd, C. M., & Murdoch, J. R. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.19 · Cited by 24
SUGAWARA, Y., AZUMA, N., ONODERA, S., TSUNOKA, Y., & Morimoto, M. (2010) · Journal of Veterinary Medical Science · doi:10.1292/jvms.10-0269 · Cited by 23
Sestrin2 protects the myocardium against radiation-induced damage
Zeng, Y.-C., Chi, F., Xing, R., Zeng, J., Gao, S., Chen, J., Wang, H.-M., Duan, Q.-Y., Sun, Y.-N., Niu, N., et al. (2016) · Radiation and Environmental Biophysics · doi:10.1007/s00411-016-0643-8 · Cited by 23
Distinct Profiles of CD163-Positive Macrophages in Idiopathic Interstitial Pneumonias
Yamashita, M., Saito, R., Yasuhira, S., Fukuda, Y., Sasamo, H., Sugai, T., Yamauchi, K., & Maemondo, M. (2018) · Journal of Immunology Research · doi:10.1155/2018/1436236 · Cited by 25
Yu Gan Long reduces rat liver fibrosis by blocking TGF-β1/Smad pathway and modulating the immunity
Xia, Y., Yu, B., Ma, C., Tu, Y., Zhai, L., Yang, Y., Liu, D., Liu, Y., Wu, H., Dan, H., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.081 · Cited by 24
Roos, A., Preuße, C., Hathazi, D., Goebel, H., & Stenzel, W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01040 · Cited by 24
Non-genetic Heterogeneity of Macrophages in Diseases—A Medical Perspective
Gessain, G., Blériot, C., & Ginhoux, F. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.613116 · Cited by 25
“Fibrotic disorders have been estimated to contribute to 45% of all deaths in the developed world (Wynn, 2004).”
BackgroundDefective Autophagy in Fibroblasts May Contribute to Fibrogenesis in Autoimmune Processes
Principe, D. D., Vona, R., Giordani, L., Straface, E., & Giammarioli, A. M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798357791 · Cited by 27
“Pathogenesis of fibrotic disorders implicates an altered balance between Th1 and Th2 cytokines [97].”
BackgroundZhang, H., Ju, B., Zhang, X., Zhu, Y., Nie, Y., Xu, Y., & Lei, Q. (2016) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12749 · Cited by 23
Zhang, H., Xiong, Y., Yang, C., Zhan, Q., Fu, Y., Luo, H., & Luo, H. (2020) · Journal of Viral Hepatitis · doi:10.1111/jvh.13352 · Cited by 22
Cardoso, F. D. O., do Valle, T. Z., Almeida-Souza, F., Abreu‐Silva, A. L., & Calabrese, K. D. S. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01986 · Cited by 27
“…fibrogenesis has been strongly linked to a Th2 response (with production of IL-4, IL-5, IL-10, and IL-13), while the predominance of IFN-γ and IL-12producing Th1 cells has been shown to almost completely attenuate the formation of tissue fibrosis (Doucet et al., 1998; Wynn, 2004; Gauglitz, 2013).”
BackgroundSobierajska, K., Wawro, M. E., & Niewiarowska, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042062 · Cited by 24
“While fibrotic disease progression is estimated to be responsible for 45% of deaths in the United States of America and the European Union [2], little is known of the molecular mechanisms responsible for its development.”
BackgroundExosomal Micro-RNAs as Intercellular Communicators in Idiopathic Pulmonary Fibrosis
Negrete-García, M. C., Ramos-Abundis, J. D. J., Alvarado‐Vásquez, N., Montes-Martínez, E., Montaño, M., Ramos, C., & Sommer, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911047 · Cited by 22
The Microbiome in Systemic Sclerosis: Pathophysiology and Therapeutic Potential
Kim, S., Park, H. J., & Lee, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416154 · Cited by 28
Polymorphisms in the NLRP3 gene and risk of primary gouty arthritis
Meng, D.-M., Zhou, Y., Wang, L., REN, W., Cui, L., Han, L., Qu, Z., Li, C., & Zhao, J. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1429 · Cited by 23
Polymorphisms in interleukin 17A gene and coal workers’ pneumoconiosis risk in a Chinese population
Han, R., Ji, X., Wu, B., Wang, T., Han, L., Yang, J., Zhu, B., & Ni, C. (2015) · BMC Pulmonary Medicine · doi:10.1186/s12890-015-0076-1 · Cited by 23
Identification of the potential targets for keloid and hypertrophic scar prevention
Zhang, L., Qin, H., Wu, Z., Chen, W., & Zhang, G. (2017) · Journal of Dermatological Treatment · doi:10.1080/09546634.2017.1421309 · Cited by 22
Imbalance toward TFH 1 cells playing a role in aberrant B cell differentiation in systemic sclerosis
Ly, N. T. M., Ueda‐Hayakawa, I., Nguyen, C. T. H., Huynh, T. N., Kishimoto, I., Fujimoto, M., & Okamoto, H. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa669 · Cited by 28
Regulation of granuloma fibrosis by nitric oxide during Mycobacterium avium experimental infection
Lousada, S., Flórido, M., & Appelberg, R. (2006) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2006.00487.x · Cited by 26
“There are several explanations for this phenomenon (Wynn 2004).”
BackgroundInfluentialRussell, S. B., Smith, J. C., Huang, M., Trupin, J. S., & Williams, S. M. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005568 · Cited by 22
Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD
Jacob, N., Targan, S. R., & Shih, D. Q. (2016) · United European Gastroenterology Journal · doi:10.1177/2050640616649356 · Cited by 53
Evaluation of the antifibrotic potency by knocking down SPARC, CCR2 and SMAD3
Ding, W., Pu, W., Jiang, S., Ma, Y., Liu, Q., Wu, W., Chu, H., Zou, H., Li, J., Wang, J., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.016 · Cited by 26
“In US, among the lethal consequence caused by different diseases, the proportion of the fibrosis takes up about 45% [2].”
BackgroundThe role of inflammatory cytokines in the development of idiopathic subglottic stenosis
Motz, K., & Gelbard, A. H. (2020) · Translational Cancer Research · doi:10.21037/tcr.2019.12.37 · Cited by 22
desJardins-Park, H. E., Chinta, M. S., Foster, D. S., Borrelli, M. R., Shen, A. H., Wan, D. C., & Longaker, M. T. (2020) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000002927 · Cited by 25
CD4+CTLs in Fibrosing Mediastinitis Linked to Histoplasma capsulatum
Allard‐Chamard, H., Alsufyani, F., Kaneko, N., Xing, K., Perugino, C. A., Mahajan, V. S., Wheat, L. J., Deepe, G. S., Loyd, J., & Pillai, S. S. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000433 · Cited by 21
Perspective on Stem Cell Therapy in Organ Fibrosis: Animal Models and Human Studies
Wiśniewska, J., Sadowska, A., Wójtowicz, A., Słyszewska, M., & Szóstek-Mioduchowska, A. Z. (2021) · Life · doi:10.3390/life11101068 · Cited by 22
Hung, C., Tsai, Y.-W., Wu, Y., Yeh, C., & Yang, K. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00850-x · Cited by 23
Schoberleitner, I., Faserl, K., Sarg, B., Egle, D., Brunner, C., & Wolfram, D. (2023) · Biomolecules · doi:10.3390/biom13020305 · Cited by 22
“, IL-4, IL-13, IL-10); Th1 cells mediate tissue damage response by Th1-related proinflammatory cytokines (IFN-y, IL-12) that suppress fibroblast-induced collagen synthesis and attenuate fibrosis [70].”
BackgroundNishikaku, A. S., Ribeiro, L. C., Molina, R. F. S., Albe, B. P., Cunha, C. D. S., & Burger, E. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2009.00663.x · Cited by 26
“brasiliensis could be due, in part, to the regulation by endogenous inhibitors of MMPs and ⁄ or by other mechanisms which involve profibrotic cytokines (Wynn 2004).”
BackgroundWard, W. K., Li, A. G., Siddiqui, Y., Federiuk, I. F., & Wang, X. (2008) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856208784909408 · Cited by 21
Ando, Y., Oku, T., & Tsuji, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162208 · Cited by 27
Carlsson, A. H., Rose, L. F., Fletcher, J. L., Wu, J. C., Leung, K. P., & Chan, R. K. (2016) · Burns · doi:10.1016/j.burns.2016.08.006 · Cited by 21
Group 2 ILCs: A way of enhancing immune protection against human helminths?
Nausch, N., & Mutapi, F. (2017) · Parasite immunology (Print) · doi:10.1111/pim.12450 · Cited by 20
Zhao, L., Shi, M., Zhou, L., Sun, H., Zhang, X., He, L., Tang, Z., Wang, C., Wu, Y., Chen, T., et al. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006251 · Cited by 24
ILC2s in infectious diseases and organ-specific fibrosis
Kindermann, M., Knipfer, L., Atreya, I., & Wirtz, S. J. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0677-x · Cited by 27
Role of IL-10 and the IL-10 Receptor in Immune Responses
Howes, A., Gabryšová, L., & O’Garra, A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.00014-3 · Cited by 25
Involvement of Periostin in Skin Function and the Pathogenesis of Skin Diseases
Kuwatsuka, Y., & Murota, H. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-6657-4_10 · Cited by 22
Sobierajska, K., Wawro, M. E., Ciszewski, W. M., & Niewiarowska, J. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.08.004 · Cited by 23
Cadherin-11 and cardiac fibrosis: A common target for a common pathology
Riley, L. A., & Merryman, W. D. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109876 · Cited by 21
Targeting Certain Interleukins as Novel Treatment Options for Liver Fibrosis
An, S. Y., Petrescu, A. D., & DeMorrow, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.645703 · Cited by 23
“Previous studies have shown that soluble IL-33 increases the secretion of Th2 cytokines such as IL-6, IL-4 and IL-13, which promote HSCs proliferation, TGF-β synthesis and fibrogenesis (Wynn, 2004; Schmitz et al., 2005).”
BackgroundCurrent and emerging drugs for idiopathic pulmonary fibrosis
Gharaee‐Kermani, M., Hu, B., Thannickal, V. J., Phan, S. H., & Gyetko, M. R. (2007) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.12.4.627 · Cited by 22
Chemokines as Immune Mediators of Liver Diseases Related to the Metabolic Syndrome
Berres, M., Nellen, A., & Wasmuth, H. E. (2010) · Digestive Diseases · doi:10.1159/000282085 · Cited by 21
Jiang, D., Huang, X., Geng, J., Dong, R., Li, S., Liu, Z., Wang, C., & Dai, H. (2016) · Oncotarget · doi:10.18632/oncotarget.9397 · Cited by 23
“The fibrosis following sarcoidosis exhibits unique characteristics that differ from those of idiopathic pulmonary fibrosis (IPF).”
BackgroundMethodInfluentialNakayama, S., Yokote, T., Hiraoka, N., Akioka, T., Nishiwaki, U., Miyoshi, T., Iwaki, K., Fumimoto, A., Masuda, Y., Hatooka, J., et al. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.01.007 · Cited by 24
Nishikaku, A. S., Molina, R. F. S., Ribeiro, L. C., Scavone, R., Albe, B. P., Cunha, C. D. S., & Burger, E. (2009) · Medical Microbiology and Immunology · doi:10.1007/s00430-009-0113-x · Cited by 27
AP-1 signaling modulates cardiac fibroblast stress responses
Whitehead, A. J., Atcha, H., Hocker, J. D., Ren, B., & Engler, A. J. (2023) · Journal of Cell Science · doi:10.1242/jcs.261152 · Cited by 23
Radiation-Induced Immune Responses from the Tumor Microenvironment to Systemic Immunity
Png, S., Tadepalli, S., & Graves, E. E. (2025) · Cancers · doi:10.3390/cancers17233849 · Cited by 21
“One of the most well-studied examples is radiation-induced lung fibrosis, where fibrotic progression is driven by chronic wound-healing Type-2 responses involving the accumulation of Tregs, T H 2 cells and M2-polarised macrophages [72,78,79].”
Uhm, J., Hamad, N., Shin, E. M., Michelis, F. V., Shanavas, M., Gupta, V. K., Kuruvilla, J. G., Lipton, J. H., Messner, H. A., Seftel, M. D., et al. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.07.001 · Cited by 20
Niu, S., & Zhang, Y. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02279-9 · Cited by 20
Cross-talk between hepatic stellate cells and T lymphocytes in liver fibrosis
Li, H., Ding, P., Peng, B., & Ming, Y. (2021) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2021.04.007 · Cited by 23
Endogenous galectin-3 is required for skeletal muscle repair
Cerri, D. G., Rodrigues, L. C., Alves, V. M., Machado, J., Bastos, V. A. F., Kettelhut, Í. D. C., Alberici, L. C., Costa, M. C. R., Stowell, S. R., Cummings, R. D., et al. (2021) · Glycobiology · doi:10.1093/glycob/cwab071 · Cited by 22
Yu, S., Long, Y., Li, D., Shi, A., Deng, J., Ma, Y., Wen, J., Li, X., Zhang, Y., Liu, S., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106339 · Cited by 21
Reißing, J., Berres, M., Strnad, P., Wree, A., Inzaugarat, M. E., Trautwein, C., Bruns, T., & Zimmermann, H. W. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.12.011 · Cited by 21
Shono, J., Sakaguchi, S., Suzuki, T., Do, M. Q., Mizunoya, W., Nakamura, M., Sato, Y., Furuse, M., Yamada, K., Ikeuchi, Y., et al. (2013) · Animal Science Journal · doi:10.1111/asj.12105 · Cited by 23
Treating skin and lung fibrosis in systemic sclerosis: a future filled with promise?
Antic, M., Distler, J. H. W., & Distler, O. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.05.016 · Cited by 23
Zhou, Q., Chen, T., Bozkanat, K. M., Ibe, J. C. F., Christman, J. W., Raj, J. U., & Zhou, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116142 · Cited by 21
Follistatin attenuates radiation-induced fibrosis in a murine model
Forrester, H. B., de Kretser, D. M., Leong, T., Hagekyriakou, J., & Sprung, C. N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173788 · Cited by 22
Leflunomide prevents ROS-induced systemic fibrosis in mice
Morin, F., Kavian, N., Chouzenoux, S., Cerles, O., Nicco, C., Chéreau, C., & Batteux, F. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.03.035 · Cited by 20
Myeloid-specific Asxl2 deletion limits diet-induced obesity by regulating energy expenditure
Zou, W., Rohatgi, N., Brestoff, J. R., Moley, J. R., Li, Y., Williams, J. W., Alippe, Y., Pan, H., Pietka, T., Mbalaviele, G., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci128687 · Cited by 22
Hou, N., Piao, X., Liu, S., Wu, C., & Chen, Q. (2015) · Infection and Immunity · doi:10.1128/iai.00517-15 · Cited by 20
Emerging drugs for idiopathic pulmonary fibrosis
Thannickal, V. J., Flaherty, K. R., Hyzy, R. C., & Lynch, J. P. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.4.707 · Cited by 21
Current best practice in the management of pulmonary and systemic sarcoidosis
Amin, E. N., Closser, D. R., & Crouser, E. D. (2014) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465814537367 · Cited by 19
“2012; Wynn, 2004].”
Prognostic Relevance of Macrophage Phenotypes in High-grade Oral Tongue Squamous Cell Carcinomas
Agarbati, S., Mascitti, M., Paolucci, E., Togni, L., Santarelli, A., Rubini, C., & Fazioli, F. (2020) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000867 · Cited by 19
An overview of disease models for NLRP3 inflammasome over-activation
Zhang, H., Zahid, A., Ismail, H., Tang, Y., Jin, T., & Tao, J. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1844179 · Cited by 24
Ma, L., Ye, Y., Lu, H. X., Xing, Y., Zhao, Z., Quan, C., Jia, Z., Lu, Y., Li, Y., & Zhou, G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.941976 · Cited by 24
“In turn, cytokines produced by activated macrophages stimulate lymphocytes, which lay the foundation for a sustained inflammatory response (5).”
BackgroundXu, X., Dai, H., & Zhang, J. (2022) · The Clinical Respiratory Journal · doi:10.1111/crj.13541 · Cited by 18
STAT6 suppression prevents bleomycin‐induced dermal fibrosis
Huang, J., Puente, H., Wareing, N. E., Wu, M., Mayes, M. D., Karmouty‐Quintana, H., Assassi, S., & Mills, T. (2023) · The FASEB Journal · doi:10.1096/fj.202200994r · Cited by 21
Guo, L., Enzan, H., Hayashi, Y., Miyazaki, E., Jin, Y., Toi, M., Kuroda, N., & Hiroi, M. (2006) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2006.07.006 · Cited by 22
A novel role of Yin-Yang-1 in pulmonary tuberculosis through the regulation of the chemokine CCL4
Rangel-Santiago, J. F., Baay-Guzman, G. J., Durán-Padilla, M. A., Lopez-Bochm, K. A., Garcia-Romero, B. L., Hernández-Cueto, D., Pantoja-Escobar, G., Vega, M. I., Hernández‐Pando, R., & Huerta‐Yépez, S. (2015) · Tuberculosis · doi:10.1016/j.tube.2015.10.013 · Cited by 19
The role of T helper 17 cells in the pathogenesis of hepatitis B virus-related liver cirrhosis
Bao, S., Zheng, J., & Shi, G. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7044 · Cited by 21
Attenuation of murine sclerodermatous models by the selective S1P1 receptor modulator cenerimod
Kano, M., Kobayashi, T., Date, M., Tennichi, M., Hamaguchi, Y., Strasser, D. S., Takehara, K., & Matsushita, T. (2019) · Scientific Reports · doi:10.1038/s41598-018-37074-9 · Cited by 22
Benedetto, P. D., Ruscitti, P., Liakouli, V., Galdo, F. D., Giacomelli, R., & Cipriani, P. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10429 · Cited by 28
Sang, L., Guo, X., Fan, H., Shi, J., Hou, S., & Lv, Q. (2022) · Cells · doi:10.3390/cells11152322 · Cited by 21
Rodriguez, A. C., Karén, J., Gardner, H., Gerdin, B., Rubin, K., & Sundberg, C. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00638.x · Cited by 19
“The amount of fibrosis is not necessarily linked to the severity of inflammation, indicating mechanisms, in part, distinct from those that regulate inflammation [6].”
BackgroundHabib, S. M., Abrahams, A. C., Korte, M. R., Zietse, R., de Vogel, L. L., Boer, W. H., Dendooven, A., Groningen, M. C. C., & Betjes, M. G. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120174 · Cited by 21
Macri, S. C., Bailey, C. C., de Oca, N. M., Silva, N. A., Rosene, D. L., Mansfield, K. G., & Miller, A. D. (2012) · Toxicologic Pathology · doi:10.1177/0192623311436177 · Cited by 21
“T cells, macrophages, and dendritic cells may play distinct and evolving roles with age, which may alter myocardial disease susceptibility and suggest that the mechanisms that drive fibrogenesis may be distinct from those that are regulating chronic inflammation (Wynn 2004, 2008).”
BackgroundThe immune mechanisms of acute exacerbations of idiopathic pulmonary fibrosis
Chen, T., Sun, W., & Xu, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1450688 · Cited by 22
Kuete, J. B. T., Kuete, J. R. N., Mbaveng, A. T., Kuete, V., Efferth, T., & Weiskirchen, R. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157242 · Cited by 18
Pulmonary involvement in systemic sclerosis: exploring cellular, genetic and epigenetic mechanisms
Doskaliuk, B., Zaiats, L., Yatsyshyn, R., Gerych, P., Cherniuk, N., & Zimba, O. (2020) · Rheumatology International · doi:10.1007/s00296-020-04658-6 · Cited by 21
Oh, A., Jeon, S., Jeong, M. G., Kim, H. K., Kang, J., Lee, Y., & Hwang, E. S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112225 · Cited by 18
Improved epicardial cardiac fibroblast generation from iPSCs
Whitehead, A. J., Hocker, J. D., Ren, B., & Engler, A. J. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.11.011 · Cited by 21
Pathologic Proteolytic Processing of N-Cadherin as a Marker of Human Fibrotic Disease
Ferrell, P. D., Oristian, K. M., Cockrell, E., & Pizzo, S. V. (2022) · Cells · doi:10.3390/cells11010156 · Cited by 22
Tumour microenvironment and heterotypic interactions in pancreatic cancer
Velasco, R. M., García, A. G., Sánchez, P. J., Sellart, I. M., & Lobo, V. J. S.-A. (2022) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-022-00875-8 · Cited by 19
Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis
Guo, R., Cheng, H., Zhang, X., Yu, Z., Wang, G., Hao, S.-Y., Gao, X.-P., & Wen, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.986199 · Cited by 20
“Th2 cytokines stimulate the synthesis of collagen, while Th1 cytokines, such as IFN-γ, by contrast, do the opposite (Wynn, 2004).”
BackgroundIKZF1 and UBR4 gene variants drive autoimmunity and Th2 polarization in IgG4-related disease
Liu, Q., Zheng, Y., Sturmlechner, I., Jain, A. K., Own, M., Yang, Q., Zhang, H., Vairo, F. P. E., Cerosaletti, K. M., Buckner, J. H., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci178692 · Cited by 22
Autologous Graft Thickness Affects Scar Contraction and Quality in a Porcine Excisional Wound Model
Chan, R. K., Rose, L. F., Wu, J. C., Tucker, D. I., Chan, M. M., Christy, R. J., Hale, R. G., & Leung, K. P. (2015) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000000426 · Cited by 18
Kato‐Kogoe, N., Ohyama, H., Nishimura, F., Meguro, M., Yoshizawa, S., Okada, Y., Nakasho, K., Yamanegi, K., Yamada, N., Hata, M., et al. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.128 · Cited by 18
Endogenous Ligands for TLR2 and TLR4 Are Not Involved in Renal Injury following Ureteric Obstruction
Chowdhury, P., Sacks, S. H., & Sheerin, N. (2010) · Nephron Experimental Nephrology · doi:10.1159/000313493 · Cited by 18
Mahmoudi, M., Fallahian, F., Sobhani, S., Ghoroghi, S., Jamshidi, A., Poursani, S., Dolati, M., Hosseinpour, Z., & Gharibdoost, F. (2017) · Clinical Rheumatology · doi:10.1007/s10067-016-3526-0 · Cited by 20
“In severe conditions of the disease, due to the release of extra collagen, internal organs are also involved [1, 2].”
BackgroundCole, E., Brown, T. A., Pinkerton, K. E., Postma, B., Malany, K., Yang, M., Kim, Y. J., Hamilton, R. F., Holian, A., & Cho, Y. H. (2017) · Inhalation Toxicology · doi:10.1080/08958378.2017.1392655 · Cited by 19
“Further, suppression of IFN-c production (contributing to a prevailing Th2 phenotype) may be associated with the progression of pulmonary fibrosis (Borthwick et al., 2013; Wynn, 2004).”
BackgroundInflammation-induced fibrosis in skeletal muscle of female carriers of Duchenne muscular dystrophy
Preuße, C., von Moers, A., Kölbel, H., Pehl, D., Goebel, H., Schara, U., & Stenzel, W. (2019) · Neuromuscular Disorders · doi:10.1016/j.nmd.2019.05.003 · Cited by 19
Recent advances in the non-invasive assessment of fibrosis using biomarkers
Tatler, A. L. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.09.010 · Cited by 18
Coppock, G., Aronson, L. R., Park, J., Qiu, C., Park, J., DeLong, J. H., Radaelli, E., Suszták, K., & Hunter, C. A. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901463 · Cited by 19
“CD4+ T cells also contribute to the proinflammatory fibrotic processes in the kidney (9, 10), and the ability of Th2 cells to produce IL-4 and IL-13 (which can enhance M2 polarization) is a major factor that promotes fibrosis (11).”
Purinergic signaling in giant cell formation
Lemaire, I. B., Falzoni, S., & Adinolfi, E. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/359 · Cited by 21
“For many intracellular bacteria, clearly an imbalance of Th1/ Th2 response is thought to contribute to the dissemination of infection and fibroproliferative disorder (24).”
BackgroundInnate Lymphoid Cells: A Promising New Regulator in Fibrotic Diseases
Zhang, Y., Tang, J., Tian, Z., van Velkinburgh, J. C., Song, J. J., Wu, Y., & Ni, B. (2015) · International Reviews of Immunology · doi:10.3109/08830185.2015.1068304 · Cited by 19
Rajamanickam, A., George, J. P., Pavankumar, N., Kumaraswami, V., Nutman, T. B., & Babu, S. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001681 · Cited by 20
Okada, M., Suzuki, K., Matsumoto, M., Takada, K., Nakanishi, T., Horikoshi, H., Higuchi, T., Hosono, Y., Nakayama, M., & Ohsuzu, F. (2009) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2008.01006.x · Cited by 18
Metadata
- Authors
- Wynn, T. A.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Wynn, Thomas A.
- ORCID
- Wynn, Thomas A.
- Venue
- Nature Reviews Immunology
- Published
- 2004-08
- Volume
- 4
- Issue
- 8
- Pages
- 583-594
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC2702150
- OpenAlex
- W1983357763
- Cited by
- 1,765
- References
- 135
- Citations by year
- 2026: 46 · 2025: 76 · 2024: 93 · 2023: 104 · 2022: 126 · 2021: 96 · 2020: 99 · 2019: 83 · 2018: 91 · 2017: 95 · 2016: 87 · 2015: 91 · 2014: 94 · 2013: 82 · 2012: 75
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (Z01AI001019, Z01AI000829)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- fibrosis, fibrogenesis, Th1/Th2 paradigm, T helper cells, idiopathic pulmonary fibrosis, liver fibrosis, systemic sclerosis, wound healing, fibroproliferative disorders
- MeSH terms
- Animals, Fibroblasts, Fibrosis, Humans, Macrophages, Transforming Growth Factor beta, Th1 Cells, Th2 Cells, Interleukin-13, Chemokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.